Skip to main content
adrian-hayday

Professor Adrian Hayday

Professor of Immunobiology

Research interests

  • Immunology

Biography

Professor Adrian Hayday is Professor of Immunobiology in the School of Immunology & Microbial Sciences.  

    Research

    experimental-oncology
    Experimental Oncology

    The Experimental Oncology Programme is focused on the development of new treatments for solid tumours.

    Project status: Ongoing

    Immunology and Immunotherapy Programme Header
    Cancer Immunology & Immunotherapy

    Cancer Immunology represents a broad field of research that studies host-tumour interactions as therapeutic targets in the treatment of cancer.

    Project status: Ongoing

    News

    Immune cell helps predict skin cancer patients chances of responding to treatment

    A type of immune cell can help predict which patients may benefit most from cancer immunotherapies, researchers from King’s College London, Guy’s and St...

    Gamma delta T cells: staying awake when others T cells have gone to sleep

    Immune cell linked to better lung cancer survival

    High levels of a unique type of immune cell is linked to a greater chance of remaining cancer-free after surgery for patients with lung cancer.

    cancer - main

    King's-Crick partnership celebrates five years

    The partnership aims to facilitate the discovery of solutions for the world’s greatest medical challenges

    Crick Lab Exterior

    King's spin-out acquired by Takeda

    Takeda Pharmaceutical Company Limited “Takeda” this week announced the exercise of its option to acquire GammaDelta Therapeutics Limited, a company focused on...

    t cells

    Poor immune response in many double- vaccinated blood cancer patients

    More than half of double vaccinated blood cancer patients have been left with little protection against COVID-19, new research has found.

    covid-19 vaccine vials

    First patients given dose to evaluate novel gamma-delta T cell cancer therapy

    A biotechnology company founded by researchers from King’s and the Francis Crick Institute has announced that it has initiated a first-in-human Phase I...

    cancer cells

    Three molecules could predict the severity of COVID-19 in patients

    A common immune signature in the blood patients has been found, which could be used to predict how severely ill a patient will become.

    covid immune

    Blood test could track immune response to COVID-19

    A highly detailed analysis of the composition of immune cells in the blood of patients with COVID-19, reveals new aspects of how the SARS-Cov-2 coronavirus...

    covid immunology

    Unique immune cell could help stop breast cancer

    A unique type of immune cell has been discovered in human breast tissue, and breast cancer patients with more of these cells are more likely to survive, finds...

    cancer.

    Researchers identify over 140 genes linked to immune system regulation

    First extensive immune profiling of mice reveals a vast catalogue of genes that regulate the immune system and model human disease

    immunology

    Features

    Transforming cancer care at King's

    King’s is the site of future breakthroughs, transforming cancer care and therapies through innovative research. An injection of philanthropic donations...

    cancer-cells-blue

    Support the King's COVID Response Fund

    You can support King's life saving research, and the mental wellbeing of our NHS staff and nursing and medical students by spreading the word or making a...

    A woman conducts lab testing

    Spotlight

    How King's continues to tackle cancer and support cancer care and research

    Saturday 4 February marks World Cancer Day. In order to honour this key date, we have highlighted some of the most important cancer-themed stories that have...

    Cancer cells

      Research

      experimental-oncology
      Experimental Oncology

      The Experimental Oncology Programme is focused on the development of new treatments for solid tumours.

      Project status: Ongoing

      Immunology and Immunotherapy Programme Header
      Cancer Immunology & Immunotherapy

      Cancer Immunology represents a broad field of research that studies host-tumour interactions as therapeutic targets in the treatment of cancer.

      Project status: Ongoing

      News

      Immune cell helps predict skin cancer patients chances of responding to treatment

      A type of immune cell can help predict which patients may benefit most from cancer immunotherapies, researchers from King’s College London, Guy’s and St...

      Gamma delta T cells: staying awake when others T cells have gone to sleep

      Immune cell linked to better lung cancer survival

      High levels of a unique type of immune cell is linked to a greater chance of remaining cancer-free after surgery for patients with lung cancer.

      cancer - main

      King's-Crick partnership celebrates five years

      The partnership aims to facilitate the discovery of solutions for the world’s greatest medical challenges

      Crick Lab Exterior

      King's spin-out acquired by Takeda

      Takeda Pharmaceutical Company Limited “Takeda” this week announced the exercise of its option to acquire GammaDelta Therapeutics Limited, a company focused on...

      t cells

      Poor immune response in many double- vaccinated blood cancer patients

      More than half of double vaccinated blood cancer patients have been left with little protection against COVID-19, new research has found.

      covid-19 vaccine vials

      First patients given dose to evaluate novel gamma-delta T cell cancer therapy

      A biotechnology company founded by researchers from King’s and the Francis Crick Institute has announced that it has initiated a first-in-human Phase I...

      cancer cells

      Three molecules could predict the severity of COVID-19 in patients

      A common immune signature in the blood patients has been found, which could be used to predict how severely ill a patient will become.

      covid immune

      Blood test could track immune response to COVID-19

      A highly detailed analysis of the composition of immune cells in the blood of patients with COVID-19, reveals new aspects of how the SARS-Cov-2 coronavirus...

      covid immunology

      Unique immune cell could help stop breast cancer

      A unique type of immune cell has been discovered in human breast tissue, and breast cancer patients with more of these cells are more likely to survive, finds...

      cancer.

      Researchers identify over 140 genes linked to immune system regulation

      First extensive immune profiling of mice reveals a vast catalogue of genes that regulate the immune system and model human disease

      immunology

      Features

      Transforming cancer care at King's

      King’s is the site of future breakthroughs, transforming cancer care and therapies through innovative research. An injection of philanthropic donations...

      cancer-cells-blue

      Support the King's COVID Response Fund

      You can support King's life saving research, and the mental wellbeing of our NHS staff and nursing and medical students by spreading the word or making a...

      A woman conducts lab testing

      Spotlight

      How King's continues to tackle cancer and support cancer care and research

      Saturday 4 February marks World Cancer Day. In order to honour this key date, we have highlighted some of the most important cancer-themed stories that have...

      Cancer cells